Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, is pleased to announce a trading update for the year ended 31 January 2020. The Company has performed ahead of expectations and anticipates reporting a 15% increase in Group revenue over the prior financial year to approximately £17.8m, including revenue from the recently acquired Viomedex business, or growth of 12% on a like for like basis. EBITDA1 is expected to be between the range of £2.0 to £2.1m, representing growth of more than 20% over the previous financial year.
The Company is pleased to report that Viomedex performed in line with expectations during the four months since acquisition and contributed to overall growth of the Group.
Neil Campbell, CEO commented “We are delighted with the results achieved this year, we had targeted double digit revenue growth and delivered it notwithstanding difficult macro-economic conditions such as Brexit. The acquisition has contributed positively and we look forward to greater contributions. This gives the Group a strong platform for continued double digit revenue growth as the Company plans for further business development.”